Nuclease resistant external guide sequences for treating inflammatory and viral related respiratory diseases

RNA interference mediated inhibition of placental growth factor gene expression using short interfering nucleic acid (sINA)

Fluoroalkoxy, nucleosides, nucleotides, and polynucleotides

2′, 5′-oligoadenylate analogs

RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of NOGO and NOGO receptor gene expression using short interfering RNA

Sequential delivery of oligomeric compounds

Dual functional oligonucleotides for use in repressing mutant gene expression

RNA interference mediated inhibition of stearoyl-CoA desaturase (SCD) gene expression using short interfering nucleic acid (siNA)

Sequence requirements for inhibitory oligonucleotides

RNA interference mediating small RNA molecules

RNA interference mediating small RNA molecules

RNA interference mediated inhibition of matrix metalloproteinase 13 (MMP13) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of platelet derived growth factor (PDGF) and platelet derived growth factor receptor (PDGFR) gene expression using short interfering nucleic acid (siNA)

Antisense modulation of TFAP2C expression

Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor

Sequence-specific inhibition of small RNA function

Modified polynucleotides for reducing off-target effects in RNA interference

RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)

Polycationic compositions for cellular delivery of polynucleotides

Hepatocyte free uptake assays

Nucleic acid mediated inhibition of enterococcus infection and cytolysin toxin activity

RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of vascular cell adhesion molecule (VCAM) gene expression using short interfering nucleic acid (siNA)

Three component chimeric antisense oligonucleotides

Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases

Antisense modulation of dual specific phosphatase 5 expression

RNA interference mediated inhibition of GRB2 associated binding protein (GAB2) gene expression using short interfering nucleic acis (siNA)

Antiviral oligonucleotides targeting viral families

RNA interference mediated treatment of polyglutamine (polyQ) repeat expansion diseases using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of intercellular adhesion molecule (ICAM) gene expression using short interfering nucleic acid (siNA)

Method of treating neurodegenerative disease

RNA interference mediated inhibition of NF-Kappa B / REL-A gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of NOGO and NOGO receptor gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (SINA)

RNA interference mediated inhibition of protein kinase C alpha (PKC-alpha) gene expression using short interfering nucleic acid (siNA)

Anti-microRNA oligonucleotide molecules

Compositions and methods for inhibiting expression of anti-apoptotic genes

RNA interference mediated inhibition of GPRA and AAA1 gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of cholinergic muscarinic receptor (CHRM3) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of protein tyrosine phosphatase type IVA (PRL3) gene expression using short interfering nucleic acid (siNA)

Antiviral oligonucleotides

SNP discriminatory siRNA

Polymearase III-based expression of therapeutic RNAs

RNA interference mediated inhibition of B-cell CLL/Lymphoma-2 (BCL-2) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of epidermal growth factor receptor (EGFR) gene expression using short interfering nucleic acid (siNA)

Chemically modified double stranded nucleic acid molecules

RNA interference mediated inhibition of cholesteryl ester transfer protein (CEPT) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of 5-alpha reductase and androgen receptor gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of ADAM33 gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of platelet-derived endothelial cell growth factor (ECGF1) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of type 1 insulin-like growth factor receptor gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of cyclin D1 gene expression using short interfering nucleic acid (siNA)

Modulation of gene expression using DNA-RNA hybrids

Hepatocyte free uptake assays

Human RNase III and compositions and uses thereof

RNA interference mediated inhibition of polycomb group protein EZH2 gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of chromosome translocation gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of angiopoietin gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of gastric inhibitory polypeptide (GIP) and gastric inhibitory polypeptide receptor (GIPR) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of Myc and/or Myb gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition 5-alpha reductase and androgen receptor gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of proliferating cell nuclear antigen (PCNA) gene expression using short interfering nucleic acid (siNA)

Methods of using mammalian RNase H and compositions thereof

RNA interference mediated inhibition of telomerase gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of early growth response gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of MDR P-glycoprotein gene expression using short interfering nucleic acid (siNA)

Antiviral oligonucleotides targeting viral families

Modulation of gene expression using DNA-DNA hybrids

RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)

Antisense oligonucleotides against tenascin for the treating of vitiligo

Antisense modulation of survivin expression

RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (SINA)

RNA interference mediated target discovery and target validation using short interfering nucleic acid (siNA)

RNA interference mediated treatment of Parkinson disease using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of alpha-1 antitrypsin (AAT) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of G72 and D-amino acid oxidase (DAAO) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of wingless gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of CXCR4 gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of acetyl-CoA-carboxylase gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of TRPM7 gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of myostatin gene expression using short interfering nucleic acid (siNA)

Method for treating cancer using IAP antisense oligomer and chemotherapeutic agent

RNA interference mediated inhibition of FAS and FASL gene expression using short interfering nucleic acid (siNA)

RNA mediated inhibition connexin gene expression using short interfering nucleic acid (siNA)

Gapped 2' modified oligonucleotides

RNA interference mediated inhibition of platelet-derived endothelial cell growth factor (ECGF1) gene expression using short interfering nucleic acid (siNA)

5'-and 3'-capped aptamers and uses therefor

Methods and compositions for modulating tissue factor

RNA interference mediated treatment of polyglutamine (polyQ) repeat expansion diseases using short interfering nucleic acid (siNA)

Novel inhibitors of poxvirus replication

Nucleic acid treatment of diseases or conditions related to levels of Ras, HER2 and HIV

RNA interference mediated inhibition of Fos gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)

Immune stimulation by phosphorothioate oligonucleotide analogs

RNA interference mediated inhibtion of tyrosine phosphatase-1B (PTP-1B) gene expression using short interfering nucleic acid (siNA)

Chimeric molecules to modulate gene expression

Modified protein kinase a-specific oligonucleotides and methods of their use

RNA interference mediated inhibition hairless (HR) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)

Use of microbiology non-viral substances for treating acne

RNA interference mediated inhibition of intercellular adhesion molecule (ICAM) gene expression using short interfering nucleic acid (siNA)

Phosphorous-linked oligomeric compounds and their use in gene modulation

Platelet derived growth factor (PDGF) nucleic acid ligand complexes

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (SiNA)

Stabilized immunomodulatory oligonucleotides

Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes

RNA interference mediating small RNA molecules

Compositions comprising alternating 2′-modified nucleosides for use in gene modulation

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

Modulation of glucagon receptor expression

RNA interference mediated inhibition of muscarinic cholinergic receptor gene expression using short interfering nucleic acid (siNA)

Oligonucleotides which inhibit expression of the OB-RGRP protein

Binding and catalytic molecules built from expanded DNA